<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30177255</article-id>
<article-id pub-id-type="pmc">6226343</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2018.07.010</article-id>
<article-id pub-id-type="manuscript">NIHMS1505724</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptomic evidence for alterations in astrocytes and parvalbumin interneurons in bipolar disorder and schizophrenia subjects</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Toker</surname>
<given-names>Lilah</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mancarci</surname>
<given-names>Burak Ogan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tripathy</surname>
<given-names>Shreejoy</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pavlidis</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada</aff>
<aff id="A2"><label>2</label>Michael Smith Laboratories, University of British Columbia, Vancouver, BC, Canada</aff>
<aff id="A3"><label>3</label>Graduate Program in Bioinformatics, University of British Columbia, Vancouver, BC, Canada</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding author:</bold> Paul Pavlidis, <email>paul@msl.ubc.ca</email>, +1-6048274157, 177 Michael Smith Laboratories, 2185 East Mall, Vancouver, BC, V6T 1Z4, Canada</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P49">Financial Disclosures</p>
<p id="P50">All authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>84</volume>
<issue>11</issue>
<fpage>787</fpage>
<lpage>796</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2018.07.010-->
<abstract id="ABS1">
<sec id="S1">
<title>Background:</title>
<p id="P1">High-throughput expression analyses of post-mortem brain tissue have been widely used to study bipolar disorder and schizophrenia. However, despite the extensive efforts, no consensus has emerged as to the functional interpretation of the findings. We hypothesized that incorporating information on cell type-specific expression would provide new insights.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P2">We re-analysed 15 publicly available bulk-tissue expression datasets on schizophrenia and bipolar disorder, representing various brain regions from eight different cohorts of subjects (unique subjects: 332 controls, 129 bipolar disorder, 341 schizophrenia). We studied changes in the expression profiles of cell type marker-genes, and evaluated whether these expression profiles could serve as surrogates for relative abundance of their corresponding cells.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P3">In both disorders, we consistently observed an increase in the expression profiles of cortical astrocytes and a decrease in the expression profiles of fast-spiking parvalbumin interneurons. No changes in astrocyte expression profiles were observed in subcortical regions. Furthermore, we found that many of the genes previously identified as differentially expressed in schizophrenia are highly correlated with the expression profiles of astrocytes or fast-spiking parvalbumin interneurons.</p>
</sec>
<sec id="S4">
<title>Conclusions:</title>
<p id="P4">Our results indicate convergence of transcriptome studies of schizophrenia and bipolar disorder on changes in cortical astrocytes and fast-spiking parvalbumin interneurons, providing a unified interpretation of numerous studies. We suggest that these changes can be attributed to alterations in the relative abundance of the cells and are important for understanding the pathophysiology of the disorders.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Gene expression</kwd>
<kwd>psychiatric disorders</kwd>
<kwd>cell types</kwd>
<kwd>cortex</kwd>
<kwd>meta-analysis</kwd>
<kwd>mitochondria</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>